Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
2.
J Neurosurg Sci ; 67(1): 1-9, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36112119

RESUMEN

INTRODUCTION: Evidence about predictors of poor outcomes such as cerebral infarction (CI) after aneurysmal subarachnoid hemorrhage (aSAH) has not been fully elucidated. EVIDENCE ACQUISITION: We performed a systematic review and meta-analysis on studies with adults with aSAH considering RCT and non-RCT, prospective, and retrospective cohort studies describing clinical, imaging as well as angiographic studies in patients with aSAH. EVIDENCE SYNTHESIS: After reviewing the complete text, 11 studies were considered eligible, out of which four were ruled out. Degree of clinical severity was the most predictive factor with a higher degree at the presentation on different severity scales being associated with a statistically significant increasing the risk of suffering a CI following aSAH (OR 2.49 [95% CI 1.38-4.49] P=0.0003). Aneurysm size increased the risk of CI (OR 1.49 [95% CI 1.20-1.85] P=0.0003; I2=4%). In six studies analyzed, it was found that an important factor for the subsequent development of CI is vasospasm (OR 7.62 [2.19, 26.54], P=0.0001). CONCLUSIONS: The development of vasospasm is a risk factor for CI development after aSAH. In our review, three factors were associated with an increased risk of CI: clinical severity at presentation, vasospasm, and aneurysm size. The major limitation of this meta-analysis is that included studies were conducted retrospectively or were post hoc analyses of a prospective trial.


Asunto(s)
Hemorragia Subaracnoidea , Vasoespasmo Intracraneal , Adulto , Humanos , Hemorragia Subaracnoidea/complicaciones , Estudios Retrospectivos , Estudios Prospectivos , Vasoespasmo Intracraneal/etiología , Infarto Cerebral/complicaciones
3.
J Neurosurg Sci ; 66(3): 251-257, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-34763389

RESUMEN

Traumatic brain injury is caused by mechanical forces impacting the skull and its internal structures and constitutes one of the main causes of morbidity and mortality in the world. Clinically, severe traumatic brain injury is associated with the development of acute lung injury and so far, few studies have evaluated the cellular, molecular and immunological mechanisms involved in this pathophysiological process. Knowing and investigating these mechanisms allows us to correlate pulmonary injury as a predictor of cerebral hypoxia in traumatic brain injury and to use this finding in decision making during clinical practice. This review aims to provide evidence on the importance of the pathophysiology of traumatic brain injury-acute lung injury, and thus confirm its role as a predictor of cerebral hypoxia, helping to establish an appropriate therapeutic strategy to improve functional outcomes and reduce mortality.


Asunto(s)
Lesión Pulmonar Aguda , Lesiones Traumáticas del Encéfalo , Hipoxia Encefálica , Lesión Pulmonar Aguda/complicaciones , Humanos , Hipoxia Encefálica/complicaciones
4.
Microorganisms ; 9(12)2021 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-34946197

RESUMEN

Among people with HIV, histoplasmosis represents an important cause of mortality. Previous studies provided estimates of the disease incidence. Here, we compared those estimates with the results obtained from a screening program implemented in Guatemala, which included histoplasmosis detection for people with HIV. To compare the results of this program with previous estimations, a literature search was performed and reports concerning histoplasmosis incidence were analyzed. The screening program enrolled 6366 patients. The overall histoplasmosis incidence in the screening program was 7.4%, which was almost double that estimated in previous studies. From 2017 to 2019, the screening program showed an upward trend in histoplasmosis cases from 6.5% to 8.8%. Histoplasmosis overall mortality among those who were newly HIV diagnosed showed a decrease at 180 days from 32.8% in 2017 to 21.2% in 2019. The screening approach using rapid diagnostic assays detects histoplasmosis cases more quickly, allowing a specific treatment to be administered, which decreases the mortality of the disease. Therefore, the use of these new techniques, especially in endemic areas of histoplasmosis, must be implemented.

5.
Arch Cardiol Mex ; 93(4): 530-531, 2021 09 30.
Artículo en Español | MEDLINE | ID: mdl-34594048

RESUMEN

Hemos leído con sumo interés el artículo publicado por Diéguez-Campa, et al.1, titulado The 2020 research pandemic: a bibliometric analysis of publications on COVID-19 and their scientific impact during the first months, en el que los autores hacen un excelente e innovador análisis bibliométrico sobre la publicación científica médica en los primeros meses de desarrollo de la pandemia de COVID-19.

6.
JRSM Open ; 12(9): 20542704211047121, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34567580

RESUMEN

Achenbach's syndrome corresponds to a pathology characterized by the appearance of ecchymoses and bruises on the fingers of the hands and eventually on the feet. It is a benign and self-limited disease, which is accompanied by pain. It generates great concern because its sudden appearance leads women who are the most affected to consult the emergency services. At present, its pathophysiology is unknown and requires knowledge of the disease to diagnose it. It is a must for poorly trained professionals.

8.
Curr Alzheimer Res ; 17(9): 781-789, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33280597

RESUMEN

Recent studies have recognized similarities between the peptides involved in the neuropathology of Alzheimer's disease and prions. The Tau protein and the Amyloid ß peptide represent the theoretical pillars of Alzheimer's disease development. It is probable that there is a shared mechanism for the transmission of these substances and the prion diseases development; this presumption is based on the presentation of several cases of individuals without risk factors who developed dementia decades after a neurosurgical procedure. This article aims to present the role of Aß and Tau, which underlie the pathophysiologic mechanisms involved in the AD and their similarities with the prion diseases infective mechanisms by means of the presentation of the available evidence at molecular (in-vitro), animal, and human levels that support the controversy on whether these diseases might be transmitted in neurosurgical interventions, which may constitute a wide public health issue.


Asunto(s)
Enfermedad de Alzheimer/etiología , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Procedimientos Neuroquirúrgicos/efectos adversos , Proteínas Priónicas/metabolismo , Proteínas tau/metabolismo , Enfermedad de Alzheimer/genética , Péptidos beta-Amiloides/genética , Humanos , Procedimientos Neuroquirúrgicos/tendencias , Proteínas Priónicas/genética , Factores de Riesgo , Proteínas tau/genética
9.
Cir Cir ; 88(5): 617-623, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33064700

RESUMEN

BACKGROUND: High blood pressure is considered a disease and at the same time a cardiovascular risk factor, mainly involved in ischemic heart disease, cerebrovascular disease and kidney failure, causing high mortality worldwide. OBJECTIVE: The objective was to follow up with 24-hour ambulatory blood pressure monitoring in patients with high blood pressure belonging to a population with high cardiovascular risk. METHOD: Descriptive, observational, retrospective study, which analyzes 24-hour outpatient pressure controls of 1858 patients, in Cartagena, Colombia. RESULTS: 1173 exams were validated and included in the study. The median age was 66 years. 66.8% (783) were women and 33.2% (390) were men. The main changes occurred during the night, when 79.1% of the patients had high systolic pressure loads, 65.6% recorded diastolic pressure averages and 83.7% had abnormal circadian patterns. Only 11% of the studies were normal in all parameters. CONCLUSIONS: 24-hour ambulatory blood pressure monitoring proved to be a useful tool to identify uncontrolled hypertensive patients, detect nocturnal hypertension and abnormal circadian patterns, which are risk markers for cardiovascular morbidity and mortality.


ANTECEDENTES: La hipertensión arterial es considerada una enfermedad y al mismo tiempo un factor de riesgo cardiovascular, involucrada principalmente en la cardiopatía isquémica, la enfermedad cerebrovascular y la insuficiencia renal, causando una elevada mortalidad. OBJETIVO: Realizar seguimiento con monitoreo ambulatorio de la presión arterial de 24 horas en pacientes con hipertensión arterial pertenecientes a una población con alto riesgo cardiovascular. MÉTODO: Estudio descriptivo, observacional, retrospectivo, en el que se analizaron los monitoreos ambulatorios de presión de 24 horas de 1858 pacientes, en Cartagena, Colombia. RESULTADOS: Se incluyeron 1173 registros. La mediana de edad fue de 66 años. El 66.8% (783) fueron mujeres y el 33.2% (390) fueron hombres. Las principales alteraciones ocurrieron durante la noche, cuando el 79.1% de los pacientes tuvieron cargas elevadas de presión sistólica, el 65.6% registraron promedios elevados de presión diastólica y el 83.7% tuvieron patrones circadianos anormales. Solo el 11% de los estudios fueron normales en todos los parámetros. CONCLUSIONES: El monitoreo ambulatorio de la presión arterial de 24 horas demostró ser una herramienta útil para identificar a los pacientes hipertensos no controlados, detectando hipertensión nocturna y patrones circadianos anormales, los cuales son marcadores de riesgo para morbilidad y mortalidad cardiovascular.


Asunto(s)
Monitoreo Ambulatorio de la Presión Arterial , Enfermedades Cardiovasculares , Hipertensión , Anciano , Presión Sanguínea , Enfermedades Cardiovasculares/epidemiología , Ritmo Circadiano , Femenino , Factores de Riesgo de Enfermedad Cardiaca , Humanos , Hipertensión/epidemiología , Masculino , Estudios Retrospectivos , Factores de Riesgo
10.
Cir Cir ; 87(3): 358-364, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31135776

RESUMEN

Traumatic brain injury according to the World Health Organization estimates that by 2020 will be the third leading cause of morbidity and mortality worldwide. Intracranial hypertension refractory to medical management is the cause of increased mortality in neurotrauma. There are various measures to control intracranial hypertension, including surgical. Decompressive craniectomy has been routinely used to treat intracranial hypertension secondary to cerebral infarction, subarachnoid hemorrhage, intracerebral hemorrhage and trauma. We review the literature to describe the mechanisms, types and indications for this procedure.


El trauma craneoencefálico, según la Organización Mundial de la salud, se estima que para el año 2020 será la tercera causa de morbimortalidad en el mundo. La hipertensión intracraneal refractaria al manejo médico es la causante de la mayor mortalidad en esta población de pacientes. Existen diversas medidas para el control de la hipertensión intracraneal, entre ellas las quirúrgicas. La craniectomía descompresiva ha sido utilizada sistemáticamente para tratar la hipertensión intracraneal secundaria al infarto cerebral, la hemorragia subaracnoidea, la hemorragia intracerebral y el trauma. Se hace una revisión de la literatura para describir los mecanismos fisiopatológicos de la lesión cerebral traumática, así como también los tipos y las indicaciones de este procedimiento.


Asunto(s)
Craniectomía Descompresiva , Hipertensión Intracraneal/cirugía , Lesiones Encefálicas/complicaciones , Craniectomía Descompresiva/métodos , Humanos , Hipertensión Intracraneal/etiología
11.
Cir Cir ; 87(2): 230-240, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30768063

RESUMEN

Ventriculitis after extraventricular drainage is a very important neurosurgical complication in neurocritical care units. It is necessary to make an early diagnosis, given that the morbidity and mortality secondary to it can be variable, and complicate the evolution of neurocritical patients. Despite this, ventriculostomy continues to be an important pillar in monitoring and treatment. Given the urgency of ventriculitis associated with multiresistant germs, new antimicrobial drugs have emerged as part of the treatment, as intraventricular routes have been proposed within the new investigations. However, the foregoing does not yet have sufficient bases to be able to support it. The present review was carried out with the aim of contributing to an early diagnosis and treatment of ventriculitis associated with extra ventricular drainage in neurocritical patients, and in this way to contribute to improve survival and prevent fatal outcomes in these patients.


La ventriculitis posterior a un drenaje extraventicular constituye una complicación neuroquirúrgica muy importante en las unidades de cuidados neurocríticos. Se hace necesario realizar un diagnóstico precoz, dado que la morbimortalidad secundaria a esta puede ser variable y complicar la evolución de los pacientes neurocríticos. A pesar de esto, la ventriculostomía continúa siendo un pilar importante en el monitoreo y el tratamiento. Ante la urgencia de ventriculitis asociadas a gérmenes multirresistentes han surgido nuevos fármacos antimicrobianos como parte del tratamiento, al igual que se han propuesto vías intraventriculares dentro de las nuevas investigaciones. Sin embargo, lo anterior aún no tiene bases suficientes para poder ­sustentarlo. La presente revisión se realizó con el objetivo de contribuir a un diagnóstico precoz y al tratamiento de la ventriculitis asociada a drenaje extraventricular en pacientes neurocríticos, y de esta forma poder mejorar la sobrevida y prevenir desenlaces fatales en estos pacientes.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Bacterianas del Sistema Nervioso Central , Ventriculitis Cerebral , Drenaje/efectos adversos , Ventriculostomía/efectos adversos , Infecciones Bacterianas del Sistema Nervioso Central/diagnóstico , Infecciones Bacterianas del Sistema Nervioso Central/tratamiento farmacológico , Ventriculitis Cerebral/líquido cefalorraquídeo , Ventriculitis Cerebral/diagnóstico , Ventriculitis Cerebral/microbiología , Ventriculitis Cerebral/terapia , Enfermedad Crítica , Drenaje/métodos , Diagnóstico Precoz , Humanos , Unidades de Cuidados Intensivos , Infecciones Relacionadas con Prótesis/líquido cefalorraquídeo , Infecciones Relacionadas con Prótesis/diagnóstico , Infecciones Relacionadas con Prótesis/tratamiento farmacológico , Infecciones Relacionadas con Prótesis/microbiología
12.
Cir Cir ; 86(6): 575-582, 2018.
Artículo en Español | MEDLINE | ID: mdl-30361715

RESUMEN

INTRODUCCIÓN: La hidrocefalia de inicio fetal, perinatal y neonatal representa un gran reto terapéutico y a menudo cursa con un pronóstico neurológico pobre, debido a su etiología heterogénea, que incluye alteraciones del neurodesarrollo. OBJETIVO: Realizar una recopilación de los avances en terapia celular como propuesta que permite ampliar el espectro de tratamiento en la hidrocefalia congénita-neonatal. DESARROLLO: Las intervenciones terapéuticas disponibles actualmente, como la derivación ventrículo-peritoneal y la tercera ventriculostomía, son insuficientes para resolver por completo la hidrocefalia y para prevenir o revertir los daños neurológicos asociados. Es por esto por lo que ha surgido la necesidad de crear nuevas alternativas terapéuticas a partir del conocimiento de los mecanismos fisiopatológicos que participan en el desarrollo de esta condición. Particularmente, la terapia celular con células madre neuronales y células madre mesenquimales ha demostrado, en estudios con animales y en estudios preclínicos con humanos, ser eficiente y segura para prevenir la hidrocefalia originada a partir de la disrupción de la zona ventricular y secundaria a la hemorragia intraventricular, con la consiguiente prevención de las secuelas neurológicas sensoriomotoras y cognitivas. CONCLUSIONES: Hasta el momento no tenemos un tratamiento eficiente que ofrezca calidad de vida a los pacientes con hidrocefalia, y que esa alternativa terapéutica sea efectiva. INTRODUCTION: Fetal hydrocephalus, perinatal and neonatal represents a major therapeutic challenge and often has with poor neurological prognosis, due to its heterogeneous aetiology, including neurodevelopmental disorders. OBJECTIVE: To make a collection of advances in cell therapy as a proposal that can extend the spectrum of treatment in congenita-neonatal hydrocephalus. DEVELOPMENT: Therapeutic interventions available at present as the ventricle-peritoneal shunt and third ventriculostomy, are insufficient to fully resolve the hydrocephalus and to prevent or reverse the associated neurological damage. This is why what has emerged the need for new therapeutic alternatives based on the knowledge of physiopathological mechanisms involved in the development of this condition. In particular, cell therapy with neural stem cells and mesenchymal stem cells has proven in animal studies and preclinical studies with humans, efficiently and safely to prevent hydrocephalus originated from the disruption of the ventricular zone and secondary to intraventricular hemorrhage, with the consequent prevention of neurological sequelae sensorimotor and cognitive. CONCLUSIONS: So far, we do not have an efficient treatment that offers quality of life to patients with hydrocephalus, and that alternative therapy to be effective.


Asunto(s)
Hidrocefalia/cirugía , Trasplante de Células Madre , Humanos , Recién Nacido
13.
J Pediatr Neurosci ; 10(2): 181-4, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26167231

RESUMEN

The iniencephaly involves a variable defect in the occipital bone, resulting in a large foramen magnum, partial or total absence of the cervical and thoracic vertebrae, accompanied by incomplete closure of arcs and/or vertebral bodies, significant shortening of the spinal column and hyperextension of the malformed cervicothoracic spine; the individual's face is deviated upward, the mandibular skin is directly continuous with anterior thorax due to the absence of neck. Its incidence is about 1:1000-1:2000 births, so this is a pretty rare neural tube defect. We present a case of iniencephaly in association with cardiovascular, spinal cord, and intracranial malformations that ended demonstrating the low survival of patients affected with this condition.

14.
J Craniovertebr Junction Spine ; 5(1): 25-32, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25013344

RESUMEN

BACKGROUND: Traditionally, conservative treatment of thoracolumbar (TL) burst fractures without neurologic deficit has encompassed the application of an extension brace. However, their effectiveness on maintaining the alignment, preventing posttraumatic deformities, and improving back pain, disability and quality of life is doubtful. OBJECTIVE: The objective was to identify and summarize the evidence from randomized controlled trials (RCTs) to determine whether bracing patients who suffer TL fractures adds benefices to the conservative manage without bracing. MATERIALS AND METHODS: Seven databases were searched for relevant RCTs that compared the clinical and radiological outcomes of orthosis versus no-orthosis for TL burst fractures managed conservatively. Primary outcomes were: (1) Loss of kyphotic angle; (2) failure of conservative management requiring subsequent surgery; and (3) disability and pain outcomes. Secondary outcomes were defined by health-related quality of life and in-hospital stay. RESULTS: Based on predefined inclusion criteria, only two eligible high-quality RCTs with a total of 119 patients were included. No significant difference was identified between the two groups regarding loss of kyphotic angle, pain outcome, or in-hospital stay. The pooled data showed higher scores in physical and mental domains of the Short-Form Health Survey 36 in the group treated without orthosis. CONCLUSION AND RECOMMENDATION: The current evidence suggests that orthosis could not be necessary when TL burst fractures without neurologic deficit are treated conservatively. However, due to limitations related with number and size of the included studies, more RCTs with high quality are desirable for making recommendations with more certainty.

15.
Surg Neurol Int ; 2: 80, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21748033

RESUMEN

BACKGROUND: The presentation of moyamoya disease (MMD) as an aneurysmal subarachnoid hemorrhage (SAH) is relatively frequent and in the absence of aneurysms is extremely rare. CASE DESCRIPTION: A 53-year-old male patient suddenly developed severe headache associated with dysarthria and an altered state of consciousness. At the time of admission, he was found drowsy with global aphasia, stiff neck, right hemiparesis and right Babinski's sign. A non-contrast brain computed tomography was performed and a small bleeding in the subarachnoid space over the left frontal and parietal cortex was observed. Four-vessel cerebral angiography showed bilateral stenosis of the internal carotid arteries, with multiple tortuous vessels branching from the anterior and middle cerebral arteries. These abnormal vessels were anastomosing with branches from the posterior cerebral and middle meningeal arteries. With this information, a diagnosis of MMD was made. A three-dimensional reconstruction from digital angiography ruled out aneurysms or vascular malformations. After 4 weeks, another angiography was performed and remained the same as previous one. CONCLUSION: Clinical and radiological characteristics of this case are consistent with previous reports, supporting the theory that non-aneurysmal SAH in MMD is caused by rupture of fragile moyamoya vessels.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA